Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats

Journal of Comparative Neurology

Volumn 388, Issue 3, 1997, Pages 484-494

  Lu, Xin ^a   Hagg, Theo ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Axotomy; Degeneration; Dopaminergic; Neurotoxicity; Parkinson's disease

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 4; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; NERVE CELL NECROSIS; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AXOTOMY; CELL DEATH; CORPUS STRIATUM; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INFUSIONS, PARENTERAL; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0030665086     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19971124)388:3<484::AID-CNE10>3.0.CO;2-M     Document Type: Article

References (37)

1. Abercrombie, U. (1946) Estimation of nuclear populations from microtome sections. Anat. Rec. 94:239-247.
2. Anderson, K.D., R.F. Alderson, C.A. Altar, P.J. DiStephano, T.L. Corcoran, R.M. Lindsay, and S.J. Wiegand (1995) Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors. J. Comp. Neurol. 357:296-317.
3. Beck, K.D., J. Valverde, T. Alexi, K. Poulsen, B. Moffat, R.A. Vandlen, A. Rosenthal, and F. Hefti (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373:339-341.
4. Bowenkamp, K.E., A.F. Hoffman, G.A. Gerhardt, M.A. Henry, P.T. Biddle, B.J. Hoffer, and A.C. Granholm (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355:479-489.
5. Frim, D.M., T.A. Uhler, W.R. Galpern, M.F. Beal, X.O. Breakefield, and O. Isacson (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA 91:5104-5108.
6. Gash, D.M., Z. Zhang, A. Ovadia, W.A. Cass, A. Yi, L. Simmerman, D. Russell, D. Martin, P.A. Lapchak, F. Collins, B.J. Hoffer, and G.A. Gerhardt (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-255.
7. Grafstein, B., and I.G. McQuarrie (1978) Role of the nerve cell body in axonal regeneration. In C.W. Cotman (ed): Neuronal Plasticity. New York: Raven Press, pp. 155-195.
8. Hagg, T., C.E.E.M. Van der Zee, G.M. Ross, and R.J. Riopelle (1997) Response to "Peterson et al., Basal forebrain neuronal loss in mice lacking neurotrophin receptor p75." Science 277:838-839.
9. Hagg, T. (1997) Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp. Neurol. (in press).
10. Hagg, T., and X. Lu (1995) GDNF prevents death but not loss of tyrosine hydroxylase of axotomized adult rat substantia nigra neurons. Soc. Neurosci. Abstr. 21:543.
11. Hagg, T., and S. Varon (1993) Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl. Acad. Sci. USA 90:6315-6319.
12. Hefti, F. (1994) Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25:1418-1435.
13. Henderson, C.E., H.S. Phillips, R.A. Pollock, A.M. Davies, C. Lemeulle, M. Armanini, L. Simmons, B. Moffet, R.A. Vandlen, V.E. Kiliatsos, and A. Rosenthal (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266:1062-1064, erratum 266:777.
14. Hökfelt, T., R. Mårtensson, A. Björklund, S. Kleinau, and M. Goldstein (1984) Distributional maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. In A. Björklund and T. Hökfelt (eds.): Handbook of Chemical Neuroanatomy, Vol. 2, part 1, Amsterdam: Elsevier.
15. Honig, M.G., and R.I. Hume (1989) Dil and diO: Versatile fluorescent dyes for neuronal labelling and pathway tracing. Trends Neurosci. 12:333-335, 340-341.
16. Humpel, C., B. Hoffer, I. Stromberg, S. Bektesh, F. Collins, and L. Olson (1994) Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience 59:791-795.
17. Jing, S., D. Wen, Y. Yu, P.L. Holst, Y. Luo, M. Fang, R. Tamir, L. Antonio, Z. Hu, R. Cupples, J.C. Louis, S. Hu, B.W. Altrock, and G.M. Fox (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113-1124.
18. Kearns, C.M., and D.M. Gash (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672:104-111.
19. Lapchak, P.A., K.D. Beck, D.M. Araujo, I. Irwin, J.W. Langston, and F. Hefti (1993) Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience 53:639-650.
20. Levivier, M., S. Przedborski, C. Bencsics, and U.J. Kang (1995) Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15:7810-7820.
21. Lin, L.F., D.H. Doherty, J.D. Lile, S. Bektesh, and F. Collins (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
22. Lindsay, R.M., S.J. Wiegand, C.A. Altar, and P.S. DiStefano (1994) Neurotrophic factors: From molecule to man. Trends Neurosci. 17:182-190.
23. Montero, C.N., and F. Hefti (1988) Resue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment. J. Neurosci. 8:2986-2999.
24. Oppenheim, R.W., L.J. Houenou, J.E. Johnson, L.F. Lin, L. Li, A.C. Lo, A.L. Newsome, D.M. Prevette, and S. Wang (1995) Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373:344-346.
25. Sauer, H., C. Rosenblad, and A. Björklund (1995) Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA 92:8935-8939.
26. Schmidt-Kastner, R., A. Tomac, B. Hoffer, S. Bektesh, B. Rosenzweig, and L. Olson (1994) Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Mol. Brain Res. 26:325-330.
27. Sofroniew, M.V., and O. Isacson (1988) Distribution of degeneration of cholinergic neurons in the septum following axotomy in different portions of the fimbria-fornix: A correlation between degree of cell loss and proximity of neuronal somata to the lesion. J. Chem. Neuroanat. 1:327-337.
28. Strömberg, I., L. Björklund, M. Johansson, A. Tomac, F. Collins, L. Olson, B. Hoffer, and C. Humpel (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124:401-412.
29. Tetzlaff, W., N.R. Kobayashi, K.M. Giehl, B.J. Tsui, S.L. Cassar, and A.M. Bedard (1994) Response of rubrospinal and corticospinal neurons to injury and neurotrophins. Progr. Brain Res. 103:271-286.
30. Tomac, A., E. Lindqvist, L.F. Lin, S.O. Ogren, D. Young, B.J. Hoffer, and L. Olson (1995a) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339.
31. Tomac, A., J. Widenfalk, L.F. Lin, T. Kohno, T. Ebendal, B.J. Hoffer, and L. Olson (1995b) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA 92:8274-8278.
32. Treanor, J.J., L. Goodman, F. de-Sauvage, D.M. Stone, K.T. Poulsen, C.D. Beck, C. Gray, M.P. Armanini, R.A. Pollock, F. Hefti, H.S. Phillips, A. Goddard, M.W. Moore, A. Buj-Bello, A.M. Davies, N. Asai, M. Takahashi, R. Vandlen, C.E. Henderson, and A. Rosenthal (1996) Characterization of a multicomponent receptor for GDNF. Nature 382:80-83.
33. Unsicker, K. (1994) Growth factors in Parkinson's disease. Progr. Growth Factor Res. 5:73-87.
34. Vidal, S.M., P.M. Villegas, G.M. Bray, and A.J. Aguayo (1988) Persistent retrograde labeling of adult rat retinal ganglion cells with the carbocyanine dye dil. Exp. Neurol. 102:92-101.
35. Williams, L.R., G. Inouye, V. Cummins, and M.A. Pelleymounter (1996) Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: Dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. J. Pharmacol. Exp. Ther. 277:1140-1151.
36. Yan, Q., C. Matheson, J. Sun, M.J. Radeke, S.C. Feinstein, and J.A. Miller (1994) Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression. Exp. Neurol. 127:23-36.
37. Yan, Q., C. Matheson, and O.T. Lopez (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373:341-344.